CEA-targeted CAR-T cells trials for Pancreatic cancer

All CEA-targeted CAR-T cells trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying CEA-targeted CAR-T cells for Pancreatic cancer

• A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
  NCT06043466 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
  NCT06006390 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
  NCT07179692 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
  NCT06126406 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study CEA-targeted CAR-T cells for Pancreatic cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.